HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N L Kozlovskaya Selected Research

N L Kozlovskaya Research Topics

Disease

5Atypical Hemolytic Uremic Syndrome
08/2023 - 01/2017
4Thrombotic Microangiopathies
08/2023 - 01/2021
3Hypertension (High Blood Pressure)
01/2022 - 06/2021
2Ischemia
01/2022 - 01/2017
2Atrial Fibrillation
12/2020 - 03/2020
2Chronic Renal Insufficiency
12/2020 - 03/2020
1Hydatidiform Mole (Molar Pregnancy)
08/2023
1Photophobia (Light Sensitivity)
01/2023
1Macular Degeneration (Age-Related Maculopathy)
01/2022
1Proteinuria
06/2021
1Infections
06/2021
1Thrombotic Thrombocytopenic Purpura
01/2021
1Hemolytic-Uremic Syndrome
01/2021
1Kidney Diseases (Kidney Disease)
12/2020
1Hemorrhage
12/2020
1Thrombosis (Thrombus)
07/2020
1Heart Failure
09/2019
1Oliguria
06/2018
1Anuria
06/2018
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2017
1Lupus Nephritis
01/2017
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2017
1Hyponatremia
01/2017
1Critical Illness (Critically Ill)
01/2017

Drug/Important Bio-Agent (IBA)

5Retinaldehyde (Retinal)IBA
01/2023 - 01/2017
3Complement System Proteins (Complement)IBA
08/2023 - 01/2017
3AnticoagulantsIBA
06/2021 - 03/2020
3CreatinineIBA
06/2021 - 06/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2023
1Biomarkers (Surrogate Marker)IBA
01/2022
1Antihypertensive Agents (Antihypertensives)IBA
06/2021
1Shiga Toxin (Shigella Toxin)IBA
01/2021
1Warfarin (Coumadin)FDA LinkGeneric
12/2020
1RivaroxabanIBA
12/2020
1Cystatin CIBA
09/2019
1eculizumabFDA Link
01/2018
1Complement Inactivating AgentsIBA
01/2018
1Complement C3 Nephritic FactorIBA
01/2017
1ElectrolytesIBA
01/2017

Therapy/Procedure

5Therapeutics
06/2021 - 01/2017
1Duration of Therapy
07/2020
1Renal Dialysis (Hemodialysis)
06/2018